Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details)

v3.24.3
Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Effect of Series A preferred dividends on net loss per share calculation $ 2.0 $ 2.0 $ 6.0 $ 6.0
Effect of partner company deemed dividends on net loss per share calculation $ 0.2 $ 0.1 $ 1.0 $ 0.4
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding     16,852,673 1,732,987
Warrants to purchase Common Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding     14,499,535 127,296
Employee Stock Option        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding     558,896 160,233
Unvested Restricted Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding     1,628,082 1,338,750
Unvested Restricted Stock Units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding     166,160 106,708